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ABSTRACT
Mellott, Alayna N. M.S., Department of Neuroscience, Cell Biology, and Physiology,
Wright State University, 2020. Divalent metal cation entry and cytotoxicity in Jurkat T
cells: role of TRPM7 channels.
Humans are exposed daily to a variety of metals that can be harmful to our immune
system. Although certain divalent metal cations are essential for numerous cellular
functions and are critical trace elements in humans, the uptake mechanisms of these ions
remain mostly unknown. Transient receptor potential melastatin 7 (TRPM7), which is
expressed in a variety of human cell types, including lymphocytes and macrophages,
conducts many divalent metal cations. TRPM7 channels are largely inactive under
normal physiological conditions due to cytoplasmic magnesium acting as a channel
inhibitor. Magnesium is a cofactor for many biochemical reactions. Low serum levels of
magnesium, hypomagnesemia, can occur from increased magnesium loss from renal or
gastrointestinal systems, redistribution of magnesium across the cell membranes, and
decreased magnesium intake. Magnesium depletion allows both physiological and nonphysiological divalent metal cations to enter through TRPM7, which is highly expressed
in T-lymphocytes. Alterations to TRPM7 channel activity by channel blockers were
found to affect the cell viability sequence. Through the use of Jurkat, a leukemic Tlymphocyte cell line which expresses high levels of TRPM7, HAP1 cells, and a TRPM7
kinase-dead mouse model, the entry of both physiological and non-physiological cations
can be quantitated by measuring cell toxicity. A cell toxicity/viability assessment in
Jurkat T-lymphocytes provided the sequence of Cd2+ > Zn2+ > Co2+ > Ni2+ > Mn2+ >>
Sr2+ ≈ Ba2+ ≈ Ca2+ ≈ Mg2. Homeostatic mechanisms alter the effects of divalent metal
cation entry and viability of T-lymphocytes, suggesting that TRPM7 in part contributes to
metal ion entry.
iii
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Introduction
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Background: Transient Receptor Potential (TRP) ion channels
Ion channels are pore forming proteins located within every living cell to allow
the movement of ions across a plasma membrane or the membrane of intracellular
organelles (Alexander SPH, 2011). Ion channels can be classified as being voltage-gated
or voltage-insensitive, meaning they are gated through second messengers or other
cellular mediators (Alexander SPH, 2011). For example, transient receptor potential
(TRP) channels facilitate transmembrane ion flux down its concentration gradient and
raise intracellular calcium and sodium ion concentrations which in turn depolarize the
cell membrane (Ramsey, Delling, & Clapham, 2006). TRP proteins commonly share six
transmembrane domains which form a tetramer to assemble a cation-permeable pore
between the fifth and sixth transmembrane segments with varying degrees of sequence
homology among its members (Figure 1) (Clapham, 2003; Venkatachalam & Montell,
2007). TRP-s can be divided into seven subfamilies based on their amino acid sequences,
namely: TRPA (ankyrin), TRPC (canonical), TRPM (melastatin), TRPML (mucolipin),
TRPN (NOMP-C homologues), TRPP (polycystin), and TRPV (vanilloid) (Park, Hong,
Kim, & So, 2014). With an exception of TRPN, which is primarily found in insects and
fish, each subfamily is present in all mammalian models studied so far (Clapham, 2003;
Lee, Moon, Cha, & Chung, 2010; Nilius & Owsianik, 2011).
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Figure 1. The mammalian TRP family. There are 6 subfamilies of TRP in
mammalian cells. Each homologue has a sequence identity as low as 20%. The
evolutionary distance between each homologue is shown through point accepted
mutation (PAM) units or the mean number of substitutions per 100 residues.
(Reproduced from Clapham, 2003 with permission)
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TRP channels are widely expressed in many cell types, including excitable and
non-excitable cells, and are localized mainly in the plasma membrane (Yee, Kazi, & Yee,
2014). The channel is functionally associated with G protein-coupled receptors (GPCRs)
and receptor tyrosine kinases (RTKs) activating phospholipase C (PLC) (Moran, Xu, &
Clapham, 2004). These cellular events can affect TRP activity by hydrolyzing
phosphatidylinositol (4,5) bisphosphate (PIP2) and giving rise to second messengers
diacylglycerol (DAG) and inositol (1,4,5) trisphosphate (IP3); causing the release of
calcium from intracellular stores such as the endoplasmic reticulum (Clapham, 1995;
Prescott & Julius, 2003). The release of intracellular calcium can activate certain TRP
and other cation channels, depolarizing the plasma membrane (Figure 2). TRP channels
mediate a variety of physiological responses through the detection of changes in
temperature, voltage, osmolarity, pH, and ion concentration (Yee et al., 2014). Calcium,
calmodulin, and magnesium are effective modulators of TRP channels that contain ion
binding domains. When intracellular calcium and magnesium concentrations are
elevated, the ions may affix to the binding domains located in the channel pore to cause
channel inhibition (Harteneck, 2003). However, for the transient receptor potential cation
channel, melastatin subfamily, member 7 (TRPM7) divalent cation binding sites have not
been identified. It is thought that Mg2+ regulates TRPM7 channels by scavenging
(screening) PIP2 phosphoinositide, which is a positive regulator of these and other TRPM
channels (Zhelay et al., 2018).

4

Figure 2. A working model for the signaling mechanisms that mediate the
cellular function of TRP channels. Activation of a G protein coupled
receptor (GPCR) or a receptor tyrosine kinase (RTK) will stimulate
phospholipase C (PLC). PLC selectively catalyzes the hydrolysis of
phosphatidylinositol (4,5) bisphosphate (PIP2) which leads to the release of
second messengers diacylglycerol (DAG) and inositol (1,4,5) trisphosphate
(IP3). IP3 stimulates calcium release through inositol trisphosphate receptor
(InsP3R), located on the endoplasmic reticulum. DAG functions is a
physiological activator of protein kinase C (PKC). The depletion of calcium
causes STIM1 to undergo a conformational change and translocate close to the
Orai/CRAC transmembrane protein. Membrane hyperpolarization will allow
calcium to enter through the Orai/CRAC channels.
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TRPM7 channel and kinase structure
TRPM7 is a unique bifunctional protein due to its expression of both a nonselective cation channel domain and a C-terminal alpha kinase domain shown in Figure 3
(Cai, Lou, Al-Saadi, Tetteh, & Runnels, 2018). TRPM7 is distinguished from other TRP
channels by its sensitivity to physiological Mg2+ (Kozak & Cahalan, 2003; Nadler et al.,
2001). Its distinctive role in divalent cation entry leads us to believe that the channel is
required for ion homeostasis and regulation. Transient receptor melastatin 6 (TRPM6), a
close homologue to TRPM7, also contains both a channel and an alpha kinase domain but
is mainly expressed in the kidney and intestine (Schlingmann et al., 2002). TRPM6 and
TRPM7 can form homo- or heterotetramers, however, several studies suggest that
TRPM6 requires the presence of TRPM7 to function properly and maintaining balanced
magnesium concentrations (Li, Jiang, & Yue, 2006; Venkatachalam & Montell, 2007).
Although in the cell most of magnesium is bound to ATP, DNA, and RNA,
approximately 5% is available as a second messenger (Feske, Wulff, & Skolnik, 2015).
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Figure 3. A schematic diagram illustrating the protein structure of
TRPM7. TRPM7 contains four Melastatin Homologous Regions (MHR) in
the N-terminal domain and six transmembrane segments with a pore between
S5 and S6. The C terminus domain contains the TRP region, followed by a
coiled coil region connecting loop to the serine/threonine-rich domains, and an
α-kinase domain.
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For TRPM7 channels, at non-physiological membrane potentials, ranging from
+50 to +100 mV, a pronounced outwardly rectifying current is detected; a small inward
current is present at negative voltages from -100 to -40 mV (Kozak, Kerschbaum, &
Cahalan, 2002; Nadler et al., 2001; Runnels, Yue, & Clapham, 2001). Inward currents
are heavily reduced due to the presence or block of extracellular divalent cations whereas
a large outward rectifying current can be recorded using whole cell patch (Figure 4).
When external divalent cations are experimentally omitted, TRPM7 currents become
semi-linear. Inclusion of divalent metal chelator in the patch pipette, such as EGTA,
allows TRPM7 channels to activate and produce a current (Ramsey et al., 2006). Native
TRPM7 currents are inhibited by free intracellular concentrations of magnesium ion at
roughly 0.5 to 1 mM. The channels will become activated upon magnesium depletion
(Romani, 2011). TRPM7 is thought to be primarily permeable to calcium and
magnesium, yet previous reports have also shown that the channel is permeable to
physiological divalent metal cations such as zinc, manganese, and cobalt as well as nonphysiological metals such as nickel, cadmium, strontium, and barium (Monteilh-Zoller et
al., 2003). In the absence of external divalent metal cations, TRPM7 is also permeable to
monovalent cations such as Na+, K+, and H+ (Kozak et al., 2002; Numata & Okada,
2008).
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Figure 4. Whole cell recording of TRPM7 current in a Jurkat T cell.
The I-V relations of TRPM7: the black trace displaying the initial current
upon rupturing of the cell membrane and the blue trace is the fully
activated TRPM7 current after intracellular magnesium depletion.
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Along with its channel domain, TRPM7 includes a functional atypical
serine/threonine protein kinase domain, located on the C terminus, which has been shown
to form a dimer that can autophosphorylate and phosphorylate downstream protein
substrates (Figure 3). The kinase is a member of the eukaryotic elongation factor 2kinase (eEF2-K) family (Matsushita et al., 2005; Middelbeek, Clark, Venselaar, Huynen,
& van Leeuwen, 2010). On the proximal end of the kinase, other TRPM6/7 α-kinase
domains can form a homodimer at residues 1548 to 1576; suggesting that TRPM7 is
essential for monomer interaction and kinase activity (Yamaguchi, Matsushita, Nairn, &
Kuriyan, 2001). The α-kinase component phosphorylates many downstream targets
involved in receptor tyrosine kinase (RTK) signaling including annexin A1, calpain II,
myosin II, PLCγ2, and SMAD2 (Romagnani et al., 2017; Zou, Rios, Montezano, &
Touyz, 2019).
Controversies regarding the channel and kinase of TRPM7
Significant efforts have been performed to determine the function of the channel
and kinase components separately. Despite many investigations, it is unclear whether the
coupling of the channel and α-kinase occur under physiological conditions. Initially, the
kinase domain was thought to be linked to the opening of the channel pore (Runnels et
al., 2001). However, more recent studies have indicated that the kinase activity is not
required for the channel to operate (Matsushita et al., 2005), although the kinase may
indirectly modulate TRPM7 gating by regulating its sensitivity to intracellular Mg2+ and
nucleotides (Demeuse, Penner, & Fleig, 2006). In the kinase-dead mouse model, where
TRPM7 kinase is inactivated, TRPM7 channel activity is not reduced (Beesetty et al.,
2018; Kaitsuka et al., 2014).
10

An early report determined the TRPM7 to be a non-selective cation channel
activated by ATP via its kinase domain (Runnels et al., 2001). Other groups have
classified the channel as being highly selective to divalent cations such as Ca2+ and Mg2+,
the latter regulating channel activity; specifically by inhibition from intracellular free
magnesium (Kozak & Cahalan, 2003; Matsushita et al., 2005) and magnesium
nucleotides (Demeuse et al., 2006; Matsushita et al., 2005; Nadler et al., 2001; Schmitz et
al., 2003). The ATP-dependent activation was later explained using Na∙ATP, which
binds magnesium, thus causing channel activation (Nadler et al., 2001). Further studies
showed that TRPM7 can be inhibited by Mg·ATP when EGTA-based chelation is used,
but that inhibition is lost when HEDTA, a strong divalent metal chelator, is present. This
suggests that free intracellular magnesium concentrations are responsible for the activity
of the channel rather than ATP (Kozak & Cahalan, 2003). Through the use of kinase
dead mice, research has shown that the channel does not require the kinase domain to
function; but the kinase may regulate CRAC channel components STIM and Orai
(Beesetty et al., 2018; Faouzi, Kilch, Horgen, Fleig, & Penner, 2017).
TRPM7 in cellular physiology and divalent metal cation entry
High expression of TRPM7 is observed in a variety of cells within the immune
system, including lymphocytes and macrophages. In mammalian cell lines, overexpressed TRPM7 is shown to have a high level of basal activity before magnesium
depletion has occurred (Matsushita et al., 2005; Monteilh-Zoller et al., 2003). TRPM7 is
reported to be responsible for maintaining cell proliferation and viability (Hanano et al.,
2004; Nadler et al., 2001). As previously mentioned, TRPM7 can conduct divalent metal
cations such as Mg2+, Ca2+, Cd2+, Mn2+, Ni2+, Zn2+, Co2+, Ba2+, and Sr2+ at low
11

concentrations; yet trivalent cations (La3+) are unable to pass through the channel (Figure
5) (Monteilh-Zoller et al., 2003). Therefore, it is possible that TRPM7 mediating the
uptake of both physiological and non-physiological metals may cause decreased viability
and proliferation of T cells and other cell types.

Figure 5. Conduction properties of TRPM7. TRPM7 can conduct many essential
divalent metal cations, in addition to several toxic metal ions as well. Previous
studies have determined TRPM7 of having a permeability sequence of: Zn2+ ≈ Ni2+
>> Ba2+ > Co2+ > Mg2+ ≥ Mn2+ ≥ Sr2+ ≥ Cd2+ ≥ Ca2+ (Nadler et al., 2001; MonteilhZoller et al., 2003). The addition of these divalent metal cations will inhibit TRPM7
from inside the cytosol (Kozak & Cahalan, 2003; Matsushita et al. 2005).
.
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Divalent metal cations are essential for maintaining proper cellular function.
Specifically, it is known that magnesium and calcium plasma concentrations must remain
within the physiological range, although there are other divalent metal cations necessary
for cells to function. Micronutrients, such as trace elements, are vital for maintaining
oxidative stress, cell regeneration, increasing aid for fighting pathogens and countless
other cellular functions (Bhattacharya, Misra, & Hussain, 2016). Trace elements found in
the human body, including zinc, chlorine, sulfur, iron, cobalt, copper, manganese,
selenium, molybdenum, and iodine maintain miniscule concentrations since these
elements are also harmful at high doses. These elements only account for 0.02% total
body weight yet contribute to many cellular processes (Wada, 2004). The divalent metal
cations mentioned in this study are listed in table 1, which highlights their importance
and toxicity in humans.
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Divalent
Metal
Cation

Symptoms in
Excessive State

Citation

N/A

Hypokalemia,
respiratory failure,
hypertension,
vomiting

(Bhoelan,
Stevering, van
der Boog, &
van der
Heyden, 2014)

N/A

N/A

Abdominal
cramps, renal
failure,
osteoporosis (itaiitai disease), heart
and liver failure

(Chakraborty,
Dutta, Sural,
Gupta, & Sen,
2013)

Calcium
(Ca2+)

Mediate vascular
contraction and
vasodilatation,
muscle function,
nerve
transmission,
intracellular
signaling,
hormonal
secretion

Osteomalacia,
Rickets, increased
parathyroid
hormone (PTH),
Osteoporosis

Kidney stones,
anorexia, fatigue,
renal
insufficiency,
prostate cancer,
constipation,

(Ross et al.,
2011)

Cobalt
(Co2+)

Formation of
Neurotransmitter
s, synthesis of
erythropoietin,
myelin sheath
repair

Disturbances in
vitamin B12
synthesis, anemia

Fibrosis in lungs,
asthma,
cardiomyopathy,
tachycardia,
decreased
cognitive activity,
increased RBCs

(Barceloux,
1999; Czarnek,
Terpiłowska, &
Siwicki, 2015)

Heightens risk for
diabetes,
neuromuscular
irritability,
cramping, seizures,
Vitamin D
resistance,
osteoporosis

Diarrhea, nausea
and vomiting,
muscle weakness,
and low blood
pressure,
sinoatrial (SA) or
atrioventricular
(AV) node blocks,
respiratory
paralysis, cardiac
arrest

(Ajib &
Childress,
2020;
DiNicolantonio
, O'Keefe, &
Wilson, 2018)

Birth defects, slow
hair and nail
growth, epilepsy,
increased serum
calcium

Neurodegenerativ
e diseases
(Parkinson’s),
mitochondrial
dysfunction,

(Avila, Puntel,
& Aschner,
2013)

Barium
(Ba2+)

Cadmium
(Cd2+)

Magnesium
(Mg2+)

Manganese
(Mn2+)

Physiological
Role

N/A

ATP production,
protein synthesis,
nerve and muscle
functioning, bone
growth,
regulation of
blood pressure
and glucose,
normal cardiac
rhythm,
maintenance of
ionic gradients
Carbohydrate
metabolite, form
metal-enzyme
complexes, bone
and connective
tissue growth

Symptoms in
Deficiency State
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Contact
dermatitis,
headaches,
cardiovascular
disease, asthma,
respiratory cancer

(Genchi,
Carocci,
Lauria,
Sinicropi, &
Catalano, 2020;
Katsuhiko
Yokoi, 2003;
Yokoi, Uthus,
& Nielsen,
2003)
(Nielsen,
Bärenholdt,
BärenholdtSchiøler,
Mauras, &
Allain, 2004;
Pors Nielsen,
2004)

(Hambidge,
2000; Plum,
Rink, & Haase,
2010; Wada,
2004)

Nickel
(Ni2+)

Aids in RNA
nucleotide
structure, iron
absorption, and
prolactin
production

Strontium
(Sr2+)

Paired with
calcium in
gastrointestinal
absorption, renal
excretion,
placental
transfer, and
mammary
secretion, bone
remodeling

Osteoporosis

Induces
hypocalcemia,
carcinogenic in
chromate form

Zinc
(Zn2+)

Nucleic acid
metabolism,
tissue repair, cell
replication,
hormone
production and
secretion

Delayed lesion
healing,
immunosuppression
, diarrhea, vomiting,
anorexia,
depression,
decreased nerve
conduction

Lethargy, altered
lymphocyte
production,
elevated risk of
prostate cancer,
diarrhea, vomiting

Reduced sperm
count, anemia

Table 1. Divalent metal cations and their physiological roles.
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Pathophysiological conditions resulting from altered magnesium uptake
Magnesium, being the fourth most abundant mineral in the human body, is an
important electrolyte required to maintain physiologic cellular and tissue functions, and
thus, its dysregulation could adversely affect cell and organ functions (Razzaque, 2018).
Normal magnesium serum levels are between 1.46 and 2.68 mg/dL, which corresponds to
0.6 mM and 1.1 mM. When serum levels fall to less than 1.46 mg/dL in the blood,
patients are categorized as magnesium deficient, hypomagnesemic (Andreozzi,
Cuminetti, Karmali, & Kamgang, 2018; Pham et al., 2014). On the opposite end of the
spectrum, patients who have increased levels of serum magnesium above 2.68 mg/dL are
diagnosed with hypermagnesemia.
Hypomagnesemia can be attributed to increased chronic alcohol use,
gastrointestinal or renal losses, or a poor diet. Hypomagnesemia is often due to reduced
consumption or inadequate absorption and/or increased excretion from the body. Many
diseases, including skeletal disorders, neurological anomalies, metabolic diseases, and
cardiovascular distress are linked to inadequate magnesium intake (Razzaque, 2018).
Individuals with type 2 diabetes are more likely to be magnesium-deficient due to
magnesium’s inverse relationship with glycemic control. Hypomagnesemia has been
demonstrated to affect glycemic control through altering cellular glucose transport,
reduction of pancreatic insulin secretion, and defective post-receptor insulin signaling
(Ahmed & Mohammed, 2019). Signs and symptoms of hypomagnesemia include mild
tremors, generalized weakness, cardiac ischemia, and in severe cases death.
Hypermagnesemia is a rare condition because the effectiveness of excess
magnesium elimination in a functioning kidney is quite high. Hypermagnesemia may
16

occur when the excessive administration of magnesium salts or magnesium-containing
drugs, for instance, laxatives are given to patients with reduced renal function (Van
Laecke, 2019). Extended hypermagnesemia results in a wide range of cardiovascular and
neuromuscular impairments such as valve blockages, fibrillations, hypotonia, respiratory
dysfunction, drowsiness and, in extreme cases, coma (Yamaguchi et al., 2019).
Pathophysiological Conditions Associated with TRPM7
TRPM7 has been recognized to regulate lymphocyte growth and proliferation
through continuous activation of phosphoinositide 3-kinase growth regulatory pathways
(Sahni & Scharenberg, 2008). In T cells, TRPM7 channel activity regulates endocytic
compartmentalization of Fas receptors after activation of the T-cell receptor (TCR),
causing apoptotic signals to be released through the Fas receptors. The deletion of
TRPM7 gene causes this apoptotic signaling to cease (Desai et al., 2012). When TRPM7
gene was completely knocked out, mice were not viable in early development (E7.5),
showing that TRPM7 is essential for embryonic development and organogenesis (Jin et
al., 2008; Stritt et al., 2016).
There are multiple cases where altered expression or activity of TRPM7 is
directly linked to pathophysiological conditions. TRPM7 directly controls cellular
processes that are critical in cancer progression such as cell migration and differentiation.
In cancerous tissues, specifically from the breast and pancreas, TRPM7 protein
expression was upregulated when compared to healthy tissues (Guilbert et al., 2013;
Rybarczyk et al., 2012). Additionally, TRPM7 appears to be linked to ischemic stroke
(Visser, Middelbeek, van Leeuwen, & Jalink, 2014). When the tissue is subjected to
prolonged oxygen and glucose deprivation, reactive oxygen species (ROS) and calcium
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floods into the cells triggering channel activation by an unknown mechanism. Several
studies have demonstrated that increased ROS and hypoxia activate TRPM7 allowing
divalent cations such as Ca2+, Mg2+ and Zn2+ to enter neurons which may increase the
likelihood of neuronal injury (Aarts et al., 2003; Inoue, Branigan, & Xiong, 2010; Visser
et al., 2014). Furthermore, TRPM7 conducts divalent metal cations, both physiological
and non-physiological, which presumptuously could cause metal toxicity (metallosis) to
occur, reducing cell viability.
The mechanistic properties of metal entry through TRPM7 have yet to be
explored. As mentioned previously, TRPM7 channels are highly expressed in Tlymphocytes, including Jurkat leukemic human T lymphocyte cell line (Chokshi,
Matsushita, & Kozak, 2012; Cui, Bian, Kagan, & McDonald, 2002; Schwarz et al.,
2007). In previous reports, it was suggested that the divalent metal cations cobalt, zinc,
and cadmium entry through TRPM7 may cause cytotoxicity (Abiria et al., 2017; Inoue et
al., 2010; Martineau et al., 2010). It is plausible that metal entry through TRPM7 can
also inhibit the channel, similar to the effect magnesium exerts (Kozak & Cahalan, 2003).
The consequences of metal entry and inhibition through TRPM7 on T-lymphocytes have
not been addressed.
Specific aims
In this study, a variety of divalent metal cations, including Mg2+, were introduced
to Jurkat T lymphocytes to determine whether TRPM7 acts as a gated entry pathway for
these ions. The first specific aim was to determine whether the entry of divalent metal
cations in Jurkat T cells was due to active TRPM7 channels. A cytotoxicity assay
revealed the accumulation of divalent metal cations within the cytosol showed a toxicity
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sequence Cd2+ > Zn2+ > Co2+ > Ni2+ > Mn2+ >> Sr2+ ≈ Ba2+ ≈ Mg2+. This sequence varied
from the permeability sequence for these ions through TRPM7 measured in patch clamp
(Monteilh-Zoller et al., 2003). Initially at 0.4 mM, cadmium was the most toxic divalent
and remained to be the most toxic when varying the concentration, whereas barium and
strontium appeared to have no toxic effect on the T cells when concentrations were
increased up to 1.4 mM. Previously, it was reported that barium and strontium are highly
permeant through TRPM7, whereas cadmium was listed lower in the permeability
sequence (Macianskiene, Martisiene, Zablockaite, & Gendviliene, 2012; Monteilh-Zoller
et al., 2003; Wei et al., 2007).
The second aim was to determine whether the addition of varying external
magnesium concentrations in the culture medium will affect TRPM7 activity. By
increasing the external magnesium concentration to 1.4 mM, TRPM7 conduction is
expected to cease, slightly protecting the cells against Mn2+, Co2+, Ni2+, and Zn2+.
TRPM7 activation occurs when magnesium is depleted from the cell: hypomagnesemia
can pathologically cause channel activation. Long-term TRPM7 channel activation may
therefore be an additional pathway for metal entry into T lymphocytes. Our final aim
was to determine whether the effect of abolished TRPM7 kinase activity affected divalent
metal cation entry through the channel pore and cytotoxicity.
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Materials & Methods
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Cell culture
Human leukemic Jurkat Clone E6-1 T cells were purchased from ATCC
(Manassas, VA). The cells were cultured in complete RPMI-1640 (Hyclone
Laboratories, Logan, UT) supplemented with 10% heat inactivated FBS (Corning,
Manassas, VA) and 100 U/ml penicillin and 100 µg/mL streptomycin (Life Technologies,
Grand Island, NY). The cells were incubated at 37°C at 5% CO2 in a cell culture
incubator (Forma). Cells were given fresh media every 48 hours and passaged by a 1:10
dilution once a week.
Human haploid leukemic cell line (HAP1), wild-type (clone C631) and TRPM7deficient (clone 10940-04), were purchased from Horizon Genomics (Vienna, Austria).
The cells were cultured in Iscove’s Modified Dulbecco’s Medium (IMDM) (Hyclone
Laboratories) supplemented with 10% heat inactivated FBS (Corning) and 100 U/ml
penicillin and 100 µg/mL (Life Technologies). Cells were maintained in a cell culture
incubator at 37°C and 5% CO2. Cells were given fresh media every 48 hours and
passaged using a 1:2 dilution when the non-treated six-well plates (Fisher Scientific,
Pittsburgh, PA) became 75% confluent.
For long term storage, cells were pelleted by centrifugation and resuspended in
their respective media containing 10% FBS and 20% DMSO (Sigma-Aldrich). The cells
were aliquoted into cryogenic storage vials (Fisher) and placed into cryo-safe cooler and
incubated overnight at -80 C°. The cells were placed into a tank containing liquid
nitrogen the following day.
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Preparation of divalent metal free RPMI
Complete RPMI-1640 is heavily supplemented with magnesium, calcium, and
other ions and nutrients (in mM): 0.41 Mg2+, 0.42 Ca2+, 5.37 KCl, 103.47 NaCl, 23.81
NaHCO3, 11.1 Glucose. By chelating or removing unwanted metal ions using
Chelex®100 sodium resin (Sigma-Aldrich, St. Louis, MO), the media can be optimized
to each experimental use.
Mouse model
Wild-type mice, C57bl/6, and TRPM7 kinase-dead knock-in mice were used for
this study. The mice were acclimated in groups of three in sterilized polypropylene cages
with free access to food and water. Kinase-dead (KD) mouse models (Matsushita et al.,
2005) are devoid of kinase activity through a point mutation encoding TRPM7 K1646R
protein. The generation of this mouse model occurred through homologous
recombination of 129/SV embryonic stem cells containing a target vector with exon 33 of
TRPM7 to sanction a point mutation from lysine to arginine (Matsushita et al., 2005).
This mutant allows the study of TRPM7 at physiological expression levels without
affecting its channel activity (Kaitsuka et al., 2014).
Splenic T-cell isolation
Mice of either sex with a mean age of 6 months and a mean weight of
approximately 24.8 g (± 1.02) were chosen for euthanasia. The mice were introduced to
a CO2 chamber with an initial gas flow of 5L/min until the mice appeared lethargic. The
gas flow is then increased to 15L/min until breathing ceases. Once the mouse is removed
from the chamber, cervical dislocation is used as s secondary measure to ensure death.
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Each mouse is sprayed down with 70% ethanol before dissecting to minimize
contamination. The spleen is removed and weighed on a scale before being rolled
between two glass slides to release the splenocytes. These cells are then passed through a
40 µm nylon cell strainer (Fisher Scientific) to remove any connective tissue. Using an
RBC lysis buffer solution (in mM): 155 NH4Cl, 10 NaHCO3, 0.1 EDTA adjusted to pH
7.4 using room temperature NaOH, erythrocytes are broken down and removed by
centrifugation (Centrisart G-16 Sartorius, Göttingen, Germany). The remaining cell
pellet is resuspended in 10 mL complete RPMI-1640 and then centrifuged once more to
ensure there is no lysis buffer left. Once again, 2 mL of complete RPMI-1640 is added to
the cell pellet. The cells and media are passed through a nylon wool fiber column
(Polysciences, Inc., Warrington, PA) for 1 hour at 37°C to purify T cells (Gibson,
Beesetty, Sulentic, & Kozak, 2016). The purified T cells were cultured in complete
RPMI-1640.
Activation of murine T lymphocytes
Phorbol 12-myristate 13-acetate (PMA) and in conjunction with ionomycin are
optimal for activating murine and human T cells (Balk, Morisi, & Gunther, 1984) (Ai, Li,
Song, Li, & Chen, 2013). Ionomycin is an ionophore which prefers to bind to calcium
ions, while PMA activates protein kinase C (PKC). The addition of each compound will
surpass the T-cell receptor yet promote intracellular signaling to activate T cells,
producing several intracellular cytokines (Ai et al., 2013). It is crucial to add PMA and
ionomycin to the T cells in less than 24 hours after the removal of the spleen. PMA and
ionomycin were added directly to the suspended T cells with [PMA] at 125 ng/mL and
[ionomycin] at 250 nM (Beesetty et al., 2018)
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Addition of divalent metal cations
Human Jurkat T lymphocytes grown in complete RPMI-1640 were transferred to
a 15 mL conical tube and centrifuged at 2,100 g for 10 minutes. The supernatant was
removed without disturbing the cell pellet. The cells were then resuspended in Chelex
treated RPMI-1640 with 10% HI- FBS and 1% penicillin streptomycin. Through the use
of a hemocytometer, cell density was approximately 2∙107 cells/ml before being split
equally into T25 flasks. The divalent cations: BaCl2, SrCl2, MnCl2, NiCl2, CoCl2, ZnSO4,
and CdCl2 were added to their respective flasks at a concentration of 0.4 mM. ZnSO4
was used instead of ZnCl2 because of the poor solubility of the latter salt. Magnesium
chloride (0.4 mM) was added to one flask with no other experimental divalent cations,
acting as a control. The flasks were then incubated at 37°C for 24-48 hours.
To determine the IC50 of each divalent ion, multiple concentrations were used in
particular experiments. All divalent metal cations were added to T-lymphocytes for 24
hours in varied concentrations. Cadmium chloride and zinc sulfate were added to Jurkats
at lower concentrations of (all in µM): 0, 10, 30, 100, and 400. Barium and strontium
chloride were tested at two concentrations (in µM): 400 and 1000. The rest of the
divalent metal cations were added at concentrations (in µM) of 0, 30, 400, and 1000.
Vi-cell XR automated cell counter
After a 24-hour incubation, Jurkat cells were placed into a falcon tube and
centrifuged at 2,100g for 10 minutes. The supernatant was discarded until there was 3
mL of chelex treated media remaining in the falcon tube. The pellet is resuspended in the
leftover media; 1 mL of solution is placed into the sample vial which is then transferred
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to the carrousel of the Beckman Coulter cell counter (Vi-cell). The Beckman Coulter cell
counter uses a trypan blue exclusion technique for estimating cell viability. Trypan blue
is mixed with the cells after the solution is imbibed into the cell counting device to
determine which cells are viable. Cells with damaged membranes will stain blue because
the trypan is able to penetrate the broken or weak membrane. Any blue colored cells or
debris will be excluded from the data collected. Cells with a healthy membrane will not
allow entry of trypan blue and are considered viable. The viable to total cells ratio will
create a percentage of how many live cells there are in a single sample (Cadena-Herrera
et al., 2015).
Drugs and solutions used
TRPM7 inhibitors were used to determine the pathway of divalent metal cation
entry. FTY720 and FTY720-P were obtained from Cayman Chemicals (Ann Arbor, MI).
NS8593 are synthesized at NeuroSerch A/S, Ballerup, Denmark and ordered through
Sigma-Aldrich. FTY720 and NS8593 were dissolved in dimethyl sulfoxide (SigmaAldrich) as concentrated stocks of 10 mM and diluted directly into the media to yield the
final concentration for each experiment. FTY720-P was dissolved using 2 mM dimethyl
sulfoxide.
The trivalents lanthanum (La3+) and gadolinium (Gd3+) block TRPM7 channel
activity. Both trivalent metals block TRPM7, but also inhibit other Ca2+ -permeable
channels such as CRAC (Zierler et al., 2011). Lanthanum (III) nitrate hexahydrate
(Sigma-Aldrich) powder was directly dissolved into chelexed-RPMI with 0.42 mM CaCl2
at two concentrations: 3 µM to block CRAC channels, and 400 µM to block both CRAC
and TRPM7 inward currents (Bouron, Kiselyov, & Oberwinkler, 2015).
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Patch-clamp electrophysiology
TRPM7 channel currents were recorded from Jurkat T lymphocytes that were
grown in 10% HI-FBS Chelex treated RPMI-1640 with the addition of 0.42 mM CaCl2
(the normal Ca2+ concentration in untreated RPMI medium). The standard external
(bathing) solution contained (in mM): 140 Na-Aspartate, 10 HEPES-Na+, 2 CaCl2, 4.5
KCl, 3 CsCl adjusted to 7.3 pH using room temperature CsOH (~307 mOsmmol/kgH2O). Before each experiment, 30 µM MgCl2 was added to the external solution. The
basic internal solution contained (in mM): 112 glutamic acid, 10 HEPES, 12 EGTA, 8
NaCl, 5 CSF, 0.09 CaCl adjusted to 7.3 pH using 143 RT CsOH (~286 mOsmmol/kgH2O). Patch solutions, both internal and external, observing TRPM7 current are rich with
aspartate, glutamate, and cesium to diminish chloride currents and inward rectifying
potassium currents (Kozak et al., 2002; Numata & Okada, 2008). To determine the
osmolarity of each solution, 50 µL of solution was added to the MICRO-OSMETTE
Automatic High Sensitivity Osmometer (Precision System Inc., Natick, MA). To ensure
consistent osmolarity readings, each sample was inserted three times into the Osmometer.
When necessary, D-mannitol (Sigma-Aldrich) was used to adjust low osmolarity.
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The addition of divalent cation metals to the media varied between experiments
and were added 24 hours prior to patching the cells. When noted with the addition of
divalent metal cations, WebMaxc software from Stanford University calculated the total
free cation concentration to add to the internal solution. Total and estimated free metal
concentrations are shown below:
Divalent Metal Cation

Concentration (mM)

Free [ion] concentration (mM)

BaCl2

13.1

Ba2+[1.4]

SrCl2

13.1

Sr2+ [1.4]

MnCl2

12.4

Mn2+[0.4]

CoCl2

12.4

Co2+[0.4]

CdCl2

12.4

Cd2+[0.4]

ZnSO4

12.4

Zn2+[0.4]

Table 2. Free ion calculations. Addition of divalent metal cations to internal
solution minus NaCl and CSF. Solutions were used at room temperature, with a
pH of 7.3 and ionic strength of 0.7.
Website:
https://somapp.ucdmc.ucdavis.edu/pharmacology/bers/maxchelator/webmaxc/w
ebmaxcS.htm

A small aliquot of Jurkat T-Lymphocytes was centrifuged at 2,100g for 10
minutes to remove the media. The cell pellet was then resuspended in room temperature
external solution and added to a glass bottom plexiglass recording chamber for patching.
While the cells are settling onto the coverslip, glass capillary tubes (Warner Instruments
LLC, Hamden, CT) were pulled using Flaming/Brown P-1000 micropipette puller (Sutter
Instrument, Novato, CA); which were then polished to resistances of 3-5 mOhm using a
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MF830 microforge (Narishige, Japan). After polishing, the patch pipette was filled with
internal solution and lowered into the glass chamber until the pipette contacted the cell
membrane. Once in contact, a slight negative pressure should be applied until there is a
maintained gigaohm seal formation which is reflective of the cell-attached configuration.
Once the cell is sealed to the micropipette (cell-attached configuration), negative pressure
or an applicable short voltage pulse will cause the membrane to break open, releasing the
internal solution through the cell membrane. This is known as the whole-cell patch
configuration. Recordings performed on the T cells used an EPC-10 patch clamp
amplifier and PatchMaster software (HEKA Elektronik). To evoke TRPM7 currents, 211
ms command voltage ramps ranging from -100 to +85 mV every 2.5 seconds were
applied for approximately 6 minutes (Chokshi et al., 2012; Zhelay et al., 2018). Data
analysis and graphing was completed using Origin v.10 (OriginLab).
Statistics
Results are presented as mean ± standard error of the mean. Data was statistically
analyzed using an unpaired Student’s t-test; significance was indicated by values of
p<.05. In figures, one asterisk denoted significance of p<.05, two asterisks denote
significance of p<.01.
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Results
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Addition of divalent metal cations to cultured Jurkat T-lymphocytes
In a series of experiments Jurkat T-lymphocytes were maintained in divalent
cation-free media to study and manipulate TRPM7 divalent cation entry. complete
RPMI-1640 with added divalent metal cations: MnCl2, CoCl2, CdCl2, NiCl2, ZnSO4,
BaCl2, SrCl2, and MgCl2 were placed into a cell viability counter (Figure 6). This was
compared to Jurkat cells introduced to Chelex-RPMI 1640 with the addition of the same
divalent metal cations (Figure 7). The majority of TRPM7 channels would be inhibited
in complete RPMI due to 0.4 mM magnesium being present. When the media is treated
with chelex resin, divalent metal ions are removed, which would be expected to favor
TRPM7 channel activation by cytosolic Mg2+ depletion. Each experiment using chelated
culture medium, contained a control group containing 0.4 mM Mg2+ which is present in
normal RPMI. The metal cations were incubated in the absence of Mg2+o to maximize
TRPM7 channel activity. Cells were exposed to the divalent metal cations for 24 to 48
hours (Figures 8 & 9). In experiments involving chelated RPMI-1640 0.42 CaCl2 was
added, which is comparable to the concentration present in complete RPMI-1640.
Majority of TRPM7 channels are inhibited by magnesium present in complete
RPMI. When Jurkat T cells are transferred to Chelex RPMI-1640 supplemented with
0.42 mM CaCl2, for prolonged periods of time, TRPM7 channels are activated. To
determine whether magnesium will inhibit TRPM7, as it is hypothesized in normal
RPMI-1640, an internal solution containing (in mM): 112 glutamic acid, 12 EGTA, 10
HEPES, 8 NaCl, 5 CSF, 0.09 CaCl and 0.7 MgCl2 (0.4 free Mg2+) was introduced to the
cell membrane. Figure 10 shows the rundown of the current leading to inhibition of
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TRPM7. Mechanistically it determines that inactive TRPM7 channels significantly
protect against divalent metal cations.
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CdCl2 ZnSO4 CoCl2 NiCl2

Figure 6. T cells in complete RPMI. Jurkat T-lymphocytes
grown in complete RPMI-1640 with 10% FBS are exposed to
divalent metal cations for 24 hours. Complete RPMI-1640
contains 0.4 mM Mg2+ which inhibits TRPM7 channels.
Cells exposed to the physiological and non-physiological
cations within 24 hours showed protection against cell death
compared to cells incubated in low Mg2+, BaCl2, SrCl2, and
MnCl2 were not measurably toxic. Less cell death occurred
with exposure to nickel chloride than cobalt chloride, zinc
sulfate, and cadmium chloride (p<0.05).
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Figure 7. T cells in chelated RPMI media. Jurkat T-lymphocytes
grown in 10% FBS, Chelex RPMI-1640 with supplemented CaCl2
(0.42 mM) exposed to divalent metal cations for 24 hours. The
removal of magnesium by chelex resin activates TRPM7 currents
which indicated increased divalent metal cation entry and cell death,
with exception of barium and strontium (p<0.05).
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Figure 8. Two-day exposure in complete RPMI. Jurkat Tlymphocytes grown in complete RPMI-1640 with 10% FBS are
exposed to divalent metal cations for 48 hours. The two-day
exposure increased cell death in all of the conditions with the
exception of strontium, barium and the magnesium control (p<0.05).
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Figure 9. Two-day exposure in chelated RPMI. Jurkat Tlymphocytes grown in chelexed RPMI-1640 with 10% FBS (no Mg2+)
are exposed to divalent metal cations for 48 hours. The two-day
exposure increased cell death in all of the conditions with the exception
of the magnesium control (p<0.05).
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Figure 10. TRPM7 current inhibition. Jurkat T cells were
grown in 10% FBS, Chelex RPMI-1640 + 0.42 mM CaCl2 for
24 hours. The cells were bathed in a calcium and cesium based
external solution during patch. Each cell was introduced to 0.7
mM magnesium chloride (0.4 mM free Mg2+) internal solution,
similar to the concentration in complete RPMI-1640, to reveal
TRPM7 inhibition through whole cell patch.
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Evaluation of barium and strontium entry through TRPM7
In previous figures, it was noted that Ba2+ and Sr2+ at the concentration of 0.4 mM
do not cause noticeable cell death. By raising concentrations of both metal cations, it was
modestly observed that strontium is not toxic to the cells. However, barium at 1 mM did
show increased cell death (Figure 11). To determine whether barium and strontium
entered cells through TRPM7, whole cell patch clamp recordings were performed. Cells
were incubated in 1.4 mM SrCl2 and BaCl2 in separate flasks containing 0.42 mM CaCl2
and no other divalent cations, for 24 hours prior to electrophysiolgical experiments
Before the experiment, cells were transferred to the recording chamber filled with
external solution containing 30 µM magnesium. The internal solution was supplemented
with 13.1 mM (1.4 mM calculated free) Ba2+ or Sr2+. Both strontium and barium, when
introduced to the channel through whole cell patch inhibited the preactivated TRPM7
currents, demonstrating that neither barium nor strontium loaded into the cell at the
concentrations applied (Figures 12 and 13).
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Figure 11. External barium and strontium exposure. Jurkat Tlymphocytes grown in Chelex-RPMI-1640 with 10% FBS are
exposed to divalent metal cations for 24 hours. At the concentration
of 0.4 mM, strontium and barium did not cause cell death. Higher
concentrations of barium chloride showed a ~15% decrease in cell
viability. Strontium at 1 mM did not produce a toxic effect to Jurkat
cells.
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Figure 12. Internal barium effect on TRPM7 current. Time dependence
of TRPM7 current inhibition by Ba2+ at internal 1.4 mM free Ba2+ (13.1 mM
BaCl2). Jurkat T cells were grown in 10% FBS, Chelex-RPMI + 0.42 CaCl2
+ 0.4 BaCl2 for 24 hours without added Mg2+.
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Figure 13. Internal strontium effect on TRPM7 current. Time
dependence of TRPM7 current inhibition by Sr2+ at internal 1.4 mM free Sr2+
(13.1 mM SrCl2). Jurkat T cells were grown in 10% FBS, Chelex-RPMI +
0.42 CaCl2 + 0.4 SrCl2 for 24 hours without added Mg2+.
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Cell viability dose-response relations for select divalent metal cations
To determine the toxicity of each divalent metal cation, Jurkat T cells were
incubated in RPMI medium with different concentrations of BaCl2, SrCl2, NiCl2, MnCl2,
CdCl2, ZnSO4, and CoCl2 for 24 hours. Trace metals such as Zn2+, Mn2+, Ni2+, and Co2+
are essential for cellular function and enzymatic reactions, yet when present in abundant
bioavailable concentrations are toxic to living organisms. For example, zinc plays an
important role in metabolic activity, cell proliferation, activates transcription factors and
regulates signal transduction pathways when present in physiological range (~2-3 g in the
average adult) (Mehri, 2020). However, high zinc intake has been linked to interference
with metabolism of other trace metals and altered lymphocyte function (Plum et al.,
2010).
The dose-response relations for various metal cations show that cadmium and
zinc appear to be toxic to T lymphocytes at significantly lower concentrations than the
rest. Cadmium proved to be the most potent divalent metal cation in the group with an
IC50 value of 15.2 µM. From the dose-response relation in Figure 14 the metal toxicity
sequence for Jurkat T cells was determined to be: Cd2+ > Zn2+ > Co2+ > Ni2+ > Mn2+ >>
Sr2+ ≈ Ba2+ ≈ Ca2+ ≈ Mg2+.
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Figure 14. Divalent metal cation dose-response curve. Jurkat Tlymphocytes grown in Chelex RPMI-1640 with 10% FBS are exposed to
divalent metal cations for 24 hours; each flask contained different
concentration of the cation. Cadmium chloride and zinc sulfate were
added to cells at lower concentrations (in µM): 0, 10, 30, 100 or 400 due
to their potency shown in Figures 6 and 7. Barium and strontium were
tested at two concentrations (in µM): 400 and 1000 due to showing little
to no toxicity (see Figure 11). The remaining divalent metal cations were
added at concentrations (in µM) of 0, 30, 400 and 1000.
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High concentrations of magnesium inhibit TRPM7
Intracellular free magnesium at concentrations ranging from 0.3 to 1 mM inhibits
TRPM7 (Chokshi et al. 2012). Under physiological conditions, T cells have 0.5 to 1 mM
free cytosolic magnesium, resulting in the majority of TRPM7 channels being inactive.
Depletion of intracellular magnesium is expected to result in activation of TRPM7
currents, and presumably increased entry of divalent metal cations. Jurkat cells were
therefore grown in Chelex-RPMI with either 8 µM free Mg2+ (10 µM HEDTA/10 µM
MgCl2) or 1.4 mM MgCl2 supplemented with 0.42 mM CaCl2 for 24 hours for depletion
or loading with Mg2+ (Luu, 2019).
Low magnesium shows preactivation of TRPM7 and growth of the outward
current shown through patch clamp recordings (Figure 15A). When the magnesium
concentration was increased to 1.4 mM in the culture medium, the current preactivation
was decreased or abolished, confirming that TRPM7 channels are tonically inhibited
under these conditions (Figure 15B). The internal solution mentioned previously
contained 1.4 mM free magnesium (total of 2.2 mM MgCl2). Dividing the current
amplitude at 5 minutes over the break-in (t=0) allowed comparisons between magnesium
concentrations affecting TRPM7 (Figure 16).
As with patch clamp experiments, cells were incubated either in the presence of 8
µM or 1.4 mM Mg2+. Separated into 2 sets of 6 flasks, divalent metal cations Cd2+, Zn2+,
Ni2+, Mn2+, or Co2+ were added to the cells, either at low or high Mg2+ concentration. As
mentioned above, low concentrations of external Mg2+ activate whereas high
concentrations inhibit channel activity. Open TRPM7 channels would be expected to
allow increased entry of each cation into the cell. Trypan blue exclusion was used to
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approximate the cytotoxicity of each ion. When TRPM7 was inhibited by 1.4 mM Mg2+,
modest protection in viability was observed for every tested ion except Cd2+ (Figure 17).
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Figure 15. Effect of high and low [Mg2+] on TRPM7 activity. Jurkat cells were
introduced to 8 µM (A) and 1.4 mM (B) concentrations of magnesium in Chelextreated RPMI-1640 for 24 hours. A. TRPM7 was preactivated at break-in when
external magnesium concentrations were lowered to 8 µM free [Mg2+]. The internal
solution contained (in mM): 112 glutamic acid, 12 EGTA, 10 HEPES, 8 NaCl, 5 CSF,
0.09 CaCl, with no additional magnesium added. Panel A shows TRPM7 current
development when magnesium is depleted within the cells. When external
magnesium concentration in culture medium was raised to 1.4 mM and 1.4 mM free
Mg2+ (2.2 mM total MgCl2) added to the internal solution, TRPM7 fully was inhibited
(B).
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Figure 16. TRPM7 sensitivity to Mg2+. Channel activity can be
examined based on the magnitude of a current differing between 8 µM
free Mg2+ and 1.4 mM magnesium chloride. Complete magnesium
concentration at 0.4 mM is also shown to indicate that TRPM7 is
inactivated. A time index can be used to determine the activity of
TRPM7 five minutes after initial break in. The voltage was examined
at a steady 83.45 mV when reading the current at initial break in and at
the 5-minute mark. (p<0.01)
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Figure 17. T cell viability with added divalent metal cations under
conditions when TRPM7 channels are active or inactive. Jurkat Tlymphocytes grown in Chelex RPMI-1640 were exposed to 0.4 mM divalent
metal cations for 24 hours. Cells were treated with 1.4 mM Mg2+ or 8 µM
Mg2+ magnesium (p<0.01).
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Channel blockers and drug concentrations
To determine whether divalent metal cations were in fact entering the cell through
TRPM7, a series of drugs known to affect TRPM7 were added to the cells. The first drug
introduced to the cells was Fingolimod, also known as FTY720 (Cayman Chemicals).
FTY720 is a synthetic sphingosine analogue that is used as an immunosuppressant in
patients who have been diagnosed with multiple sclerosis. For TRPM7 channels,
FTY720-P did not produce any noticeable effect and was not toxic to Jurket T cells.
FTY720, on the other hand, was somewhat toxic, especially at a higher concentration
(Figure 18). In previous studies, FTY720 at low concentrations ranging from 1 to 3 µM,
was an effective inhibitor of TRPM7 currents (Qin et al., 2013). In Figure 19, 2 µM
FTY720 and FTY720 phosphate were added to the cells along with divalent metal cations
and incubated for 24 hours. This concentration was chosen to minimize the toxic effect
while still effectively inhibiting TRPM7 (Figure 20).
The next drug tested on the Jurkat T cells was NS8593. NS8593 is a small
conductance Ca2+ -activated K+ channel modulator, which is also a potent blocker of
TRPM7 channels at an IC50 of 1.6 µM (Chubanov et al., 2012; Strøbaek et al., 2006).
Two concentrations of NS8593 were used to diminish or abolish TRPM7 currents: 1 µM
NS8593 does not affect TRPM7 while blocking SK channels, whereas 20 µM NS8593
completely suppresses both the inward and outward TRPM7 currents together with SK
channels. As shown in Figure 20, when cells were incubated in the presence of 20 µM of
NS8593 for 24 hours, there was significant protection against killing by MnCl2, NiCl2,
and CoCl2.
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Figure 18. FTY720 and FTY720-P effects on viability. Jurkat Tlymphocytes grown in Advanced Chelex-RPMI supplemented with
5% FBS were exposed to FTY720 and FTY720-P for 24 hours at two
concentrations to determine toxicity. Reduced FBS formulation was
used to minimize nonspecific binding of the drugs to serum.
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Figure 19. Viabilities of T cells exposed to FTY720 and FTY720-P. Jurkat
T-lymphocytes grown in Advanced Chelexed-RPMI-1640 with 5% FBS
were exposed to FTY720 and FTY720-P at 2 µM. Based on Figure 18 and
the control group (0.4 MgCl2) shown above, FTY720 but not FTY720-P was
toxic to cells (p<0.05).
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Trivalent metal cations such as lanthanides are unable to conduct through TRPM7
but block the pore of the channel and inhibit its activity. In particular, lanthanum (III)
nitrate, La(NO3)3, at 400 µM completely blocks the inward TRPM7 currents as well as
CRAC currents, whereas 1 µM will only inhibit CRAC currents. The high concentration
of 400 µM of lanthanum appeared to significantly protect against toxicity of the divalent
metal cations, with the exception of nickel (Figure 21).
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Figure 20. Viabilities of Jurkat T cells exposed to divalent metal cations
and NS8593. Jurkat T-lymphocytes grown in Chelex RPMI-1640
supplemented with 10% FBS were exposed to divalent metal cations for 24
hours. Cells were treated either with 1 µM NS8593, which blocks SK
channels or with 20 µM NS8593 which blocks both SK and TRPM7 channels
(p<0.01)
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Figure 21. Viabilities of Jurkat T cells exposed to divalent metal
cations and La(NO3)3. Jurkat T-lymphocytes grown in Chelex RPMI1640 with 10% FBS were exposed to divalent metal cations for 24 hours.
Cells were either treated with 3 µM La(NO3)3 which blocks CRAC
channels or with 400 µM La(NO3)3 which blocks both CRAC and
TRPM7 channels (p<0.05).
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Divalent metal cation entry estimated by recording endogenous TRPM7 channel
activity in Jurkat T cells
To determine whether the selected divalent metal cations entered specifically
through TRPM7, whole cell patch-clamp electrophysiology was performed. TRPM7
channels are largely inactivated when 0.4 mM magnesium is present. When the internal
solution containing no magnesium is introduced, TRPM7 current activation will occur
due to magnesium depletion from the cytosol (Figure 22). Cells were once again
incubated in the presence of manganese, cobalt, nickel, zinc, and cadmium at 0.4 mM in
Chelex treated RPMI and 0.42 mM CaCl2.
Each divalent metal cation was added to their respective flask for various times
depending on their toxicity to the cell. Manganese and nickel were added 24 hours prior
to patching whereas nickel was added 12 hours before patching; zinc and cadmium were
added 6 hours before patching. The internal solution contained (in mM): 112 glutamic
acid, 10 HEPES, 12 EGTA, 0.09 CaCl2, and 12.4 experimental divalent metal cation (0.4
free ion concentration). Accordingly, each ion could enter through TRPM7 and inhibited
the channel (Figures 23-27).
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Figure 22. Whole-cell recording of TRPM7 current development in a
Jurkat T-cell. Cells grown in complete RPMI (0.4 mM Mg2+) will maintain
inactivated TRPM7. Internal solution with no magnesium will show
development of TRPM7 over time due to magnesium depletion. Jurkats were
introduced to 30 µM MgCl2 in the external solution. Intracellular Mg2+ will
decrease in concentration, allowing TRPM7 to become activated and produce a
current.
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Figure 23. Effects of 0.4 mM MnCl2 on TRPM7 activation in Jurkat T cells.
Jurkat T cells were introduced to 0.4 mM MnCl2 for 24 hours within 10% FBS
Chelexed RPMI 1640. Panel A shows inhibition of TRPM7 through a time
course when the cells were grown over night with manganese chloride. The
internal solution also contained 12.4 mM MnCl2 (calculated free Mn2+ of 0.4
mM). To ensure that cells could develop a current, the same cells were
introduced to a manganese free internal solution. A current was produced and
TRPM7 was activated shown in panel B.
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Figure 24. Effects of 0.4 mM NiCl2 on TRPM7 activation in Jurkat T cells.
Jurkat T cells were introduced to 0.4 mM NiCl2 for 24 hours within 10% FBS
Chelexed RPMI 1640. Panel A shows inhibition of TRPM7 through a time course
when the cells were grown over night with nickel chloride. The internal solution
also contained 12.4 mM NiCl2 (0.4 mM free Ni2+). To ensure that cells could
develop a current, the same cells were introduced to a nickel free internal solution.
A current was produced and TRPM7 was activated shown in panel B.
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Figure 25. Effects of 0.4 mM CoCl2 on TRPM7 activation in Jurkat T
cells. Jurkat T cells were incubated in 0.4 mM CoCl2 for 12 hours within
10% FBS Chelexed RPMI 1640. Panel A shows inhibition of TRPM7
through a time course when the cells were grown over night with cobalt
chloride. The internal solution also contained 12.4 mM CoCl2 (0.4 mM free
Co2+). To ensure that cells could develop a current, the same cells were
introduced to a cobalt free internal solution. A current was produced and
TRPM7 was activated shown in panel B.
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Figure 26. Effects of 0.4 mM ZnSO4 on TRPM7 activation in Jurkat T cells.
Jurkat T cells were incubated in 0.4 mM ZnSO4 for 6 hours within 10% FBS
Chelexed RPMI 1640. Panel A shows inhibition of TRPM7 through a time course
when the cells were grown over night with zinc sulfate. The internal solution also
contained 12.4 mM ZnSO4 (0.4 mM free Zn2+). To ensure that cells could
develop a current, the same cells were introduced to a zinc free internal solution.
A current was produced and TRPM7 was activated shown in panel B.

58

A.
100

B.
I (pA)
I (pA)
250

200

150

50

100

50

n=4
0
0

100

200

n=2

0

300

0

Time (sec)

100

200

Time (sec)

Figure 27. Effects of 0.4 mM CdCl2 on TRPM7 activation in Jurkat T
cells. Jurkat T cells were incubated in 0.4 mM CdCl2 for 6 hours within 10%
FBS Chelexed RPMI 1640. Panel A shows inhibition of TRPM7 through a
time course when the cells were grown over night with cadmium chloride.
The internal solution also contained 12.4 mM CdCl2 (0.4 mM free Cd2+). To
ensure that cells could develop a current, the same cells were introduced to a
cadmium free internal solution. A current was produced and TRPM7 was
activated shown in panel B.
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TRPM7 deficient (KO) HAP1 cells
To further determine if divalent cation entry occurred specifically through
TRPM7, human leukemia haploid with deficient TRPM7 was evaluated. HAP1 is a nearhaploid human cell line that was derived from a male patient with chronic myeloid
leukemia. Haploid, meaning one pair of chromosomes, allows gene editing software
such as CRISPR/Cas9 to quickly introduce mutations. In this case, CRISPR/Cas9 is able
to remove TRPM7 function through the depletion of 17 base pairs in exon 4 and compare
it to endogenous TRPM7 (Chubanov, Ferioli, & Gudermann, 2017).
In absence of TRPM7, cells introduced to divalent metal cations for 20 hours
showed rescue compared to HAP1s expressing endogenous TRPM7 (Figure 28). In
regular cell conditions, HAP1 cells are grown in IMDM which normally contains 1.4 mM
CaCl2. To ensure divalent cations were completely removed, each HAP1 experiment used
Chelexed RPMI and conditioned with 1.4 mM CaCl2 to enhance the probability of
viability of the cells before the addition of the metals.
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Figure 28. Wildtype and TRPM7 CRISPR knockout HAP1 cells exposed to
divalent metal cations. HAP1 cells were placed into Chelexed RPMI-1640 with the
addition of 1.4 CaCl2, mimicking the concentration found in IMDM. Divalent metal
cations were added to both the wildtype and TRPM7 deficient cells for 20 hours.
Exposure time was decreased due to the reduced viability of the control group in
previous experiments; data not shown. HAP1 KO cells show rescue against
manganese, nickel and cobalt. (p<0.05)
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Kinase-dead mouse model
TRPM7 is unique in its structure because it comprises of both an ion channel and
an atypical protein α-kinase (APKs). Copious studies have explored the consequences of
removing or inactivating the TRPM7 kinase, although the impact of the missing kinase
activity on the stability of the channel remains controversial (Cai et al., 2018). In
previous research the kinase domain was shown to regulate downstream signaling targets
such as Ef2-k, annexin-1, PLCϒ2, calpain, and myosin IIA heavy chain; which is
understood to be involved in cell migration through phosphorylation (Antunes et al.,
2016; Guilbert et al., 2013).
Considering that TRPM7 is an ion channel that is covalently linked to a protein
kinase, there is a possibility that a kinase mutation may affect divalent metal cation entry
and cell viability. To determine whether channel activity is affected by the
serine/threonine kinase of TRPM7, a kinase dead (KD) mutated mouse model was
developed as previously discussed within the methods. Kinase dead mice display a slight
decrease in the density of T cells in the spleen and lymph nodes (Beesetty et al., 2018).
By inactivating TRPM7 kinase activity T-cell activation induced blastogenesis,
proliferation and cytokine expression is impaired, in theory due to the defective
upregulation or functional kinetics of Ca2+ and Mg2+ dependent pathways (Beesetty et al.,
2018). T cells were extracted and purified from the spleen of wildtype and kinase-dead
mice. After extraction, T cells were either activated using PMA and ionomycin or
directly added into Chelex-RPMI with divalent metal cations, construing the cells as
inactivated. After 24 hrs, PMA/ionomycin was removed and cells were transferred to
Chelex-RPMI containing divalent metal cations at 0.4 mM. Viability measurements were
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taken 24 hours later (48 hours after activation). TRPM7 protein expression is upregulated
upon activation of T cells yet are not regulated through kinase activity (Beesetty et al.,
2018). After 24-hour exposure to the divalent metal cations in both activated and
inactivated T cells for wildtype and KD mice, cell viability was assessed (Figures 29 and
30).
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Figure 29. Murine wildtype and kinase-dead resting splenic T
cells exposed to divalent metal cations. Wildtype and kinase dead
resting T cells exposed to 0.4 mM divalent metal cations for 24
hours. The cells were kept in 10% FBS, Chelexed RPMI 1640 with
0.42 mM CaCl2 immediately after isolation.
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Figure 30. Murine wildtype and kinase-dead activated
splenic T cells exposed to divalent metal cations. After
isolation, the splenic T cells were treated with PMA and
ionomycin for 24 hours prior to the addition of the divalent
metal cations. The activated T cells were then exposed to 0.4
mM divalent metal cations for another 24 hours. The cell
culture medium was Chelex-RPMI 1640 supplemented with
10% FBS and 0.42 mM CaCl2 (p<0.05).
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Discussion
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Summary of results
Divalent metal cations, specifically trace metals, are often required for a variety of
cellular functions. Normally, only small quantities of essential metals are required to
maintain a homeostatic environment. Large doses of trace metals will have toxic effects
on cells, organs, and organ systems (Yaman, Kaya, & Yekeler, 2007). Non-physiological
metals or heavy metals are widespread in industrialized societies and can contaminate the
environment, leading us to be exposed to these pollutants (Jan et al., 2015). Metal
accumulation can evoke innate immunity and T-cell mediated responses (Lehmann, Sack,
& Lehmann, 2011), yet the uptake mechanisms of these essential and non-essential
divalent metal cations have yet to be fully elucidated.
T lymphocytes highly express the ion channel Transient Receptor Potential
Melestatin 7 (TRPM7) (Beesetty et al., 2018; Chokshi et al., 2012). TRPM7 has been
proposed to regulate cell viability and maintain Mg2+ homeostasis (Nadler et al., 2001;
Schmitz et al., 2003). Previous research has shown TRPM7 to conduct several divalent
metal cations such as Zn2+, Mn2+, Co2+, Ni2+, Cd2+, Sr2+, Ba2+, and Ni2+ in HEK293 cells
overexpressing this protein (Monteilh-Zoller et al., 2003). Therefore, it is possible that
TRPM7 also contributes to divalent metal cation entry in T lymphocytes. The first
specific aim of this study was to observe divalent metal cation entry via TRPM7 channels
in Jurkat T cells by determining their effect on cell viability. The next specific aim was
to characterize the importance of high and low concentrations of magnesium on TRPM7
ion conduction. Jurkat, a leukemic T-lymphocyte cell line which highly expresses
TRPM7, is an excellent model to quantify divalent metal entry through the TRPM7
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channel. The final specific aim was to determine whether inactivation of TRPM7 kinase
affected divalent metal cation entry and cell viability. Splenic T cells were isolated from
wildtype and kinase-dead mice. The experiments performed to answer these specific
aims focused on using a cell viability counter, whole cell patch clamp of Jurkat T cells to
examine endogenous TRPM7 activity and splenic T cell isolation from a murine mouse
model.
To determine the potency of each metal, Jurkat T cells were grown in either
complete RPMI or Chelex-RPMI with the addition of 0.4 mM of each divalent metal
cation for 1 to 2 days (see Figures 6-9). It was observed that barium and strontium had
the least effect on T cells, whereas cadmium and zinc had strong toxicity in every
experiment. There was a noticeable protection in cells that were placed in complete
RPMI and therefore had inhibited TRPM7 channels, compared to cells grown in Chelextreated medium with activated TRPM7. Presumably, any divalent metal cation that
passes through the membrane should have a toxic effect on the cell and also inhibit
TRPM7 (Figure 10). It was previously reported that the TRPM7 channel shows a
permeability sequence of Zn2+ ≈ Ni2+ >> Ba2+ > Co2+ > Mg2+ ≥ Mn2+ ≥ Sr2+ ≥ Cd2+ ≥
Ca2+. Our toxicity/viability measurements, on the other hand, provided a viability
sequence of Cd2+ > Zn2+ > Co2+ > Ni2+ > Mn2+ >> Sr2+ ≈ Ba2+ ≈ Ca2+ ≈ Mg2+.
In all experiments, Cd2+ was extremely potent, even though it was shown to be the
least conductive in the permeability sequence obtained from electrophysiological
measurements. By contrast, Ba2+ and Sr2+ are highly permeant through TRPM7 yet were
not toxic (Figure 11). In Figures 12 and 13, 1.4 mM Ba2+ or Sr2+ were introduced to
Jurkat T cells for 24 hours in Chelex-RPMI. Whole cell recordings were performed to
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determine whether these divalent cations entered the cell. We did not observe inhibition
of TRPM7 which strongly suggested that neither Ba2+ or Sr2+ entered the cells. Nickel,
manganese, and cobalt were moderately toxic in each experiment. A toxicity doseresponse was performed for each divalent metal cation. Based on previous viability
assessments, each metal was given a specific concentration range to determine its doseresponse and IC50. Figure 14 visualizes the dose-response and IC50 of each divalent
metal cation to further validate the viability sequence.
By measuring endogenous TRPM7 channel activity in Jurkat T cells exposed to
varying Mg2+ concentrations we can determine how different magnesium concentrations
affect TRPM7 activity. When T cells are exposed to a low concentration of Mg2+, 8 µM,
TRPM7 will become preactivated and produce a large current at break-in (see
Figure15a). As external Mg2+ concentrations are raised, the channels will become
progressively inhibited (see Figure 15b). TRPM7 channel activity was quantified by
determining a time index for each cell (I5min/I˳) which reflects the fraction of channels
open at 5 minutes in an intact cell at a given Mg2+ concentration (Figure 16). Viability
was estimated using 0.4 mM divalent metal cations on Jurkat T cells containing either
activated or inactivated TRPM7. Moderate protection against each divalent metal cation,
with the exception cadmium, was observed when TRPM7 was inactivated using external
1.4 mM MgCl2 (Figure 17).
To determine whether these divalent metals are in fact entering through TRPM7,
a series of inhibitors were added to chelated media for 24 hours. Initially, a synthetic
sphingosine analogue, FTY720 and the phosphorylate, FTY720-P, was added to the
media. Concentration of 1 to 3 µM FTY720 can inhibit TRPM7. FTY720-P is unable to
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inhibit TRPM7 due to the additional phosphate group, therefore it was used as the control
in Figure 19. Figure 19 displays a significant difference between the control group using
2 µM FTY720 and FTY720-P when only magnesium was present. Therefore, two
concentrations of FTY720 and FTY720-P were tested on Jurkat T lymphocytes with no
other divalent metal cations added. The viability shown in figure 18 determined that
FTY720 alone produces a toxic effect.
Due to the adverse effects of FTY720 on the T cells, NS8593 was added to the
cells. NS8593 can efficiently block TRPM7 as well as small-conductance calciumactivated potassium channels (SK channels) expressed in Jurkat cells. The channel
segments of TRPM7 and KCa2.1–2.3 indicate similar drug binding sites interfering with
the gating of these channels (Chubanov et al., 2017). As shown in Figure 20, two
concentrations of NS8593 were used at 1 µM, NS8593 does not affect TRPM7 currents
while blocking SK channels completely. By raising the concentration of NS8593 to 20
µM, both TRPM7 and SK currents are blocked. When cells were incubated overnight
with 20 µM of NS8593 plus the added divalent metal cations, the cell viability
measurements displayed modest protection against Mn2+, Ni2+, and Co2+.
TRPM7 does not conduct trivalent metal cations such as lanthanum (La3+) or
gadolinium (Gd3+); therefore, these trivalent metals can be used as effective inhibitors of
TRPM7 channel activity. In particular, lanthanum (III) nitrate, La(NO3)3, can be used to
block both TRPM7 and CRAC channels due to their similar pharmacological properties.
When cells are exposed to 400 µM lanthanum nitrate for 24 hours, TRPM7 and CRAC
currents will diminish completely while 1 µM will only inhibit CRAC currents. With the
addition of 400 µM La(NO3)3, significant protection against each divalent metal cation,
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with the exception of Ni2+ (Figure 21) was observed. It needs to be noted that La3+
cannot be considered a specific blocker at such high concentrations since it can block
other ion channels as well.
TRPM7 is rendered largely inactive under physiological conditions due to
cytoplasmic magnesium acting as a channel inhibitor. When magnesium is depleted from
the cell, the channels will begin to activate (Figure 22). Each divalent metal cation was
added to the Jurkat cells for up to 24 hours prior to patch clamp. Figures 23-27a display
whole cell recording when manganese, cobalt, nickel, zinc, and cadmium were added to
the cells and the internal solution. Figures 23-27b show that a current does activate when
the metal is not present in the internal solution, acting as a control.
To further investigate divalent metal cation entry specifically through TRPM7,
human leukemia haploid (HAP1) cells with deficient TRPM7 were assessed. In the
absence of TRPM7, KO HAP1 cells were introduced to divalent metal cations for 20
hours which showed moderate viability rescue from Mn2+, Ni2+, and Co2+ when
compared to HAP1 cells expressing endogenous TRPM7 (see Figure 28). A TRPM7
kinase deficient mouse model (kinase-dead) was also evaluated to determine whether
kinase activity affected divalent metal cation entry and cell survival. Splenic T cells
isolated from both mouse models were either resting or activated by PMA and
ionomycin. Figure 29 compares the viability of WT and KD resting splenic cells with the
addition of 0.4 mM divalent metal cations. The viabilities of the WT and KD cells were
not significantly different, although the toxicity of each metal followed the Jurkat
viability sequence. Previous research indicates that TRPM7 kinase activity plays an
important part in murine T-cell activation (Beesetty et al., 2018). Through the addition of
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125 ng/mL PMA and ionomycin at 250 nM for 24 hours, the isolated T cells will become
activated. The divalent metal cations were then added for another 24 hours before
measuring the viability (Figure 30). The viability appeared to be decreased when
compared to the resting cells. This may be explained through the extended 24 hours
needed to activate the cells. Another possibility is that PMA/ionomycin could potentially
be toxic to the T cells although this is less likely. Ultimately, each divalent metal appears
to have minimal toxic effect on any of the splenic T cells isolated from the WT and KD
mice.
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Conclusions
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T lymphocytes express high protein levels of TRPM7, which could be a plausible
mechanism for the uptake of toxic metals. Through a series of experiments using patch
clamp, a cell viability counter, and splenic T cell isolations, our specific aims can be
observed. The first specific aim was to determine whether endogenous TRPM7 in Jurkat
T cells can conduct both physiological and non-physiological divalent metal cations. By
growing Jurkat T cells for 1 to 2 days in Chelex RPMI containing 0.4 mM divalent metal
cations, we can examine the potency of each metal and determine a viability sequence. A
series of cell viability counts determined a toxicity/viability sequence to be: Cd2+ > Zn2+
> Co2+ > Ni2+ > Mn2+ >> Sr2+ ≈ Ba2+ ≈ Ca2+ ≈ Mg2+. Presumably, if these metal ions can
enter the cell, they should produce a toxic effect. Previous research has discovered a
permeability sequence of divalent metal cation entry through TRPM7 channels. In each
experiment Cd2+ was the most toxic in cell viability assays, yet it is known to conduct
through TRPM7 rather poorly. Conversely, Ba2+ did not reduce cell viability yet was
shown to be highly conductive through the channel. Strontium is not particularly
conductive through TRPM7 and there was no indication of killing the Jurkat cells.
Nickel, manganese, and cobalt were determined to be moderately toxic. Furthermore, our
studies agree with Haase et al. 2015 which determined that Cd2+, Zn2+, and Ni2+ are toxic
to Jurkat T cells (Haase, Hebel, Engelhardt, & Rink, 2015)
Through Mg2+ loading or the addition of TRPM7 blockers (FTY720, La3+, and
NS8593) TRPM7 currents should be eliminated. The elimination of TRPM7 should
rescue the cells from each divalent metal cation. Our findings determined that minimal
rescue occurred when there was TRPM7 inactivation. TRPM7 does contribute to
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minimal metal uptake, apart from Sr2+ and Ba2+ which showed incomplete inhibition of
TRPM7 (Figures 12 and 13). However, other studies have exhibited Ba2+ and Sr2+ entry
through TRPM7 at higher concentrations ranging from 10 to 100 mM. It is possible that
the addition of Ba2+ and Sr2+ at lower concentrations does not influence TRPM7 activity.
As previously mentioned, TRPM7 is highly expressed in Jurkat T cells, thus
activation of the channel should increase metal uptake. Through whole cell patch it was
discovered that internal solution containing each toxic divalent metal cation will cause
inhibition of the channel. This could explain why TRPM7 does not contribute to
extensive metal uptake. There are a variety of other metal uptake pathways available for
divalent metal cations to enter through Jurkat T cells, yet TRPM7 is the only Mg2+inhibited channel. Ion channels in Jurkats have been extensively studied. The variety of
TRPM7 blockers used in this study can block other channels such as CRAC and SK. The
inhibition of CRAC and SK rules out the possibility of being an alternative pathway for
metal entry.
Our second specific aim was to characterize the importance of high and low
concentrations of magnesium’s effect on TRPM7 conduction. TRPM7 channel activity
depends on external Mg2+ concentrations. Through measuring endogenous TRPM7
currents grown under varying concentrations of Mg2+ will affect TRPM7 activity. When
8 µM free magnesium is added to the Jurkat T cells for 24 hours, TRPM7 will become
preactivated and produce a sizeable current. In normal media (i.e. containing serum and
divalent metal cations), 0.4 mM MgCl2 is present; rendering most TRPM7 channels to be
inactive. As Mg2+ concentrations rise, the channel will remain inactivated. Next, we
wanted to determine whether Mg2+ loading would greatly increase the viability of the
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Jurkat T cells when exposed to toxic divalent metal cations. Divalent metal cation entry
has not been greatly affected by the magnesium block. Although TRPM7 is hypothesized
to maintain Mg2+ homeostasis, other divalent metal cations are most likely conducted
through other pathways that are not inhibited by intracellular Mg2+.
For the final specific aim, the effect of inactivating TRPM7 kinase activity on its
channel properties was investigated in splenic T cells isolated from WT and KD mice.
Based on the current findings, the divalent metal cations did not affect either wildtype or
kinase-dead splenic T cell count. Although the kinase plays a significant role during Tcell activations, it is unclear whether kinase activity affects divalent metal cation entry
through the pore or cell survival.
Future directions
There is a plethora of channels located on immune cells that contribute to divalent
metal cation entry other than TRPM7. Using other drug blockers, we may be able to
examine the specific channel that is responsible for contributing the greatest uptake of
each metal through Jurkat T lymphocytes. Of course, there are also a variety of immune
cells that contain TRPM7, excluding T cells, which may impact metal absorption;
plausibly leading to immunosuppression. Further examination of divalent metal cations
affecting the kinase of TRPM7 in murine mouse models could enhance our knowledge on
how the channel and kinase reacts to non-physiological metal concentrations upon entry.
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